Trial data show an average increase of about 2.7 to 3.2 beats per minute in some studies, and real-world program data report a slightly higher proportion of people reporting increased heart rate on semaglutide versus not on it (for example, roughly 16 percent versus 11 percent after two years in an extensive registry analysis)
Meet the Wegovy Pill Lose 14-15% of your body weight* A new, FDA-approved way to take Wegovy, no injections required
Dosing errors have also occurred with compounded tirzepatide products, which many compounding pharmacies or facilities offer as an alternative to Mounjaro or Zepbound
A provider may recommend semaglutide if: You prefer a medication with a longer track record You have specific cardiovascular considerations You respond well to GLP-1 therapy A provider may recommend tirzepatide if: Maximizing weight loss is a primary goal You have insulin resistance You qualify medically and can tolerate the medication Because every patient responds differently, a personalized consultation is essential
For ongoing maintenance at 2.4mg, you need roughly 2 vials per month